Vijaya Diagnostic Centre Limited (VIJAYA.BO)
INR 1059.65
(-1.01%)
INR 1059.65
(-1.01%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.47 Billion INR | 19.29% |
| 2022 | 4.59 Billion INR | -0.68% |
| 2021 | 4.62 Billion INR | 22.82% |
| 2020 | 3.76 Billion INR | 11.15% |
| 2019 | 3.38 Billion INR | 15.8% |
| 2018 | 2.92 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.56 Billion INR | 0.65% |
| 2023 Q1 | 1.21 Billion INR | 0.05% |
| 2023 Q2 | 1.38 Billion INR | 14.71% |
| 2023 Q3 | 1.32 Billion INR | -4.44% |
| 2023 FY | 5.47 Billion INR | 19.29% |
| 2023 Q4 | 1.55 Billion INR | 16.97% |
| 2022 Q1 | 1.04 Billion INR | -9.99% |
| 2022 FY | 4.59 Billion INR | -0.68% |
| 2022 Q4 | 1.2 Billion INR | 6.96% |
| 2022 Q3 | 1.13 Billion INR | -6.32% |
| 2022 Q2 | 1.2 Billion INR | 15.7% |
| 2021 Q2 | 1.12 Billion INR | -8.13% |
| 2021 FY | 4.62 Billion INR | 22.82% |
| 2021 Q4 | 1.15 Billion INR | 4.66% |
| 2021 Q3 | 1.1 Billion INR | -1.71% |
| 2021 Q1 | 1.22 Billion INR | 9.82% |
| 2020 Q1 | 517.02 Million INR | 0.0% |
| 2020 Q2 | 1.13 Billion INR | 118.84% |
| 2020 Q3 | 998.83 Million INR | -11.72% |
| 2020 FY | 3.76 Billion INR | 11.15% |
| 2020 Q4 | 1.11 Billion INR | 11.85% |
| 2019 FY | 3.38 Billion INR | 15.8% |
| 2018 FY | 2.92 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 6.19 Billion INR | 11.592% |
| Dr. Lal PathLabs Limited | 22.26 Billion INR | 75.396% |
| Metropolis Healthcare Limited | 12.07 Billion INR | 54.641% |
| Thyrocare Technologies Limited | 5.71 Billion INR | 4.21% |
| Vimta Labs Limited | 3.18 Billion INR | -72.125% |